Citigroup’s C4 Therapeutics CCCC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $32.6K | Sell |
22,816
-20,579
| -47% | -$29.4K | ﹤0.01% | 4220 |
|
|
2025
Q1 | $69.4K | Sell |
43,395
-14,981
| -26% | -$24K | ﹤0.01% | 4008 |
|
|
2024
Q4 | $210K | Sell |
58,376
-45,592
| -44% | -$164K | ﹤0.01% | 3555 |
|
|
2024
Q3 | $593K | Buy |
103,968
+73,512
| +241% | +$419K | ﹤0.01% | 2888 |
|
|
2024
Q2 | $141K | Sell |
30,456
-740,272
| -96% | -$3.42M | ﹤0.01% | 3335 |
|
|
2024
Q1 | $6.3M | Buy |
770,728
+635,255
| +469% | +$5.19M | ﹤0.01% | 1124 |
|
|
2023
Q4 | $765K | Buy |
135,473
+77,579
| +134% | +$438K | ﹤0.01% | 2377 |
|
|
2023
Q3 | $108K | Buy |
57,894
+39,492
| +215% | +$73.5K | ﹤0.01% | 3219 |
|
|
2023
Q2 | $50.6K | Buy |
18,402
+16,983
| +1,197% | +$46.7K | ﹤0.01% | 3967 |
|
|
2023
Q1 | $4.46K | Sell |
1,419
-77,388
| -98% | -$243K | ﹤0.01% | 4274 |
|
|
2022
Q4 | $465K | Sell |
78,807
-25,276
| -24% | -$149K | ﹤0.01% | 2587 |
|
|
2022
Q3 | $913K | Buy |
104,083
+99,385
| +2,115% | +$872K | ﹤0.01% | 2180 |
|
|
2022
Q2 | $36K | Sell |
4,698
-19,120
| -80% | -$147K | ﹤0.01% | 3996 |
|
|
2022
Q1 | $578K | Sell |
23,818
-58,658
| -71% | -$1.42M | ﹤0.01% | 2759 |
|
|
2021
Q4 | $2.66M | Buy |
82,476
+15,712
| +24% | +$506K | ﹤0.01% | 1766 |
|
|
2021
Q3 | $2.98M | Sell |
66,764
-8,728
| -12% | -$390K | ﹤0.01% | 1615 |
|
|
2021
Q2 | $2.86M | Buy |
75,492
+17,888
| +31% | +$677K | ﹤0.01% | 1835 |
|
|
2021
Q1 | $2.13M | Buy |
57,604
+55,584
| +2,752% | +$2.06M | ﹤0.01% | 1892 |
|
|
2020
Q4 | $67K | Buy |
+2,020
| New | +$67K | ﹤0.01% | 3922 |
|